HK1078580A1 - Antitumoral analogs of lamellarins - Google Patents

Antitumoral analogs of lamellarins

Info

Publication number
HK1078580A1
HK1078580A1 HK06100423.1A HK06100423A HK1078580A1 HK 1078580 A1 HK1078580 A1 HK 1078580A1 HK 06100423 A HK06100423 A HK 06100423A HK 1078580 A1 HK1078580 A1 HK 1078580A1
Authority
HK
Hong Kong
Prior art keywords
lamellarins
antitumoral
analogs
antitumoral analogs
stereoisomer
Prior art date
Application number
HK06100423.1A
Other languages
English (en)
Inventor
Christian Bailly
Solloso Andres Francesch
Urbano Maria Cristina Mateo
Guerrero Jose Antonio Jimenez
Del Castillo Alfredo Pastor
Marchante Carmen Cuevas
Original Assignee
Pharma Mar Sau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sau filed Critical Pharma Mar Sau
Publication of HK1078580A1 publication Critical patent/HK1078580A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
HK06100423.1A 2002-08-13 2006-01-11 Antitumoral analogs of lamellarins HK1078580A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0218816.7A GB0218816D0 (en) 2002-08-13 2002-08-13 Antitumoral analogs of lamellarins
PCT/GB2003/003541 WO2004014917A2 (en) 2002-08-13 2003-08-13 Antitumoral analogs of lamellarins

Publications (1)

Publication Number Publication Date
HK1078580A1 true HK1078580A1 (en) 2006-03-17

Family

ID=9942234

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100423.1A HK1078580A1 (en) 2002-08-13 2006-01-11 Antitumoral analogs of lamellarins

Country Status (17)

Country Link
US (1) US7396837B2 (xx)
EP (2) EP2138496A1 (xx)
JP (1) JP2005536529A (xx)
KR (1) KR20050053613A (xx)
CN (2) CN1688585A (xx)
AT (1) ATE475663T1 (xx)
AU (1) AU2003252997B2 (xx)
CA (1) CA2493725A1 (xx)
DE (1) DE60333578D1 (xx)
GB (1) GB0218816D0 (xx)
HK (1) HK1078580A1 (xx)
IL (1) IL166513A0 (xx)
MX (1) MXPA05001731A (xx)
NO (1) NO20051282L (xx)
NZ (1) NZ537935A (xx)
RU (1) RU2328500C2 (xx)
WO (1) WO2004014917A2 (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112300232A (zh) * 2020-11-03 2021-02-02 浙江大学 Lamellarin D糖基化衍生物及其制备和应用

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071587B2 (en) 2009-05-27 2011-12-06 N. V. Organon (Dihydro)imidazoiso[5,1-A]quinolines
TW201116531A (en) 2009-07-29 2011-05-16 Organon Nv Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
US8431564B2 (en) 2009-07-29 2013-04-30 Merck Sharp & Dohme B.V. Ring-annulated dihydropyrrolo[2,1-α]isoquinolines
WO2011035417A1 (en) * 2009-09-25 2011-03-31 Aegera Therapeutics Inc. Hsp-90 binding compounds, compositions thereof, and their use fn the treatment of autoimmune and inflammatory diseases
JP5888702B2 (ja) * 2011-01-17 2016-03-22 国立大学法人 長崎大学 抗癌活性化合物
WO2012126084A1 (en) * 2011-03-24 2012-09-27 Pharmascience Inc. Hsp-90 binding compounds, compositions thereof, and their use iν the treatment and prevention of fungal infections
KR101721029B1 (ko) * 2014-10-16 2017-03-29 연세대학교 산학협력단 인돌리지노[3,2-c]퀴놀린 유도체, 이의 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 낭포성 섬유증 예방 또는 치료용 약학조성물
TWI674265B (zh) * 2017-03-27 2019-10-11 東海大學 片螺素及其衍生物之製造方法
EP3604312B1 (en) 2017-03-29 2023-11-29 Nagasaki University Fourth-generation egfr tyrosine kinase inhibitor
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852033A (en) * 1995-06-29 1998-12-22 Pharma Mar, S.A. Methods of treatment using lamellarin-class alkaloids
AUPO656597A0 (en) * 1997-05-02 1997-05-29 Australian National University, The Preparation of therapeutic compounds
AUPP433398A0 (en) * 1998-06-25 1998-07-16 Australian National University, The Compounds and processes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112300232A (zh) * 2020-11-03 2021-02-02 浙江大学 Lamellarin D糖基化衍生物及其制备和应用
CN112300232B (zh) * 2020-11-03 2021-11-09 浙江大学 Lamellarin D糖基化衍生物及其制备和应用

Also Published As

Publication number Publication date
EP2138496A1 (en) 2009-12-30
IL166513A0 (en) 2006-01-15
CA2493725A1 (en) 2004-02-19
NZ537935A (en) 2007-02-23
DE60333578D1 (de) 2010-09-09
EP1551844B1 (en) 2010-07-28
MXPA05001731A (es) 2005-08-16
WO2004014917A2 (en) 2004-02-19
WO2004014917A3 (en) 2004-05-13
NO20051282L (no) 2005-05-11
ATE475663T1 (de) 2010-08-15
AU2003252997B2 (en) 2009-08-06
RU2005106863A (ru) 2005-11-10
RU2328500C2 (ru) 2008-07-10
AU2003252997A1 (en) 2004-02-25
EP1551844A2 (en) 2005-07-13
US7396837B2 (en) 2008-07-08
GB0218816D0 (en) 2002-09-18
KR20050053613A (ko) 2005-06-08
JP2005536529A (ja) 2005-12-02
CN101941977A (zh) 2011-01-12
CN1688585A (zh) 2005-10-26
US20060173030A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
HK1078580A1 (en) Antitumoral analogs of lamellarins
DE69831868D1 (en) Antithrombosemittel
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
AP2002002637A0 (en) Novel piperazine
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
MY134129A (en) Polymorphs of an epothilone analog
MY140987A (en) Specific glucocorticosteroid compound having anti-inflammatory activity
EP2266623A3 (en) Prodrugs containing novel bio-cleavable linkers
BG106013A (en) New compounds and compositions as protease inhibitors
EP1019045A4 (en) ANTITHROMBOTIC AGENTS
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
CA2511255A1 (en) 2-piperidone derivatives as prostaglandin agonists
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
WO2004091504A3 (en) Substituted quinobenzoxazine analogs
EP1274443A4 (en) MICELLES
AU2001286768A1 (en) Novel macrocycles and uses thereof
WO2005077926A3 (en) Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease
MY138826A (en) 2,7-substituted indoles
AU3952997A (en) Arylsulfonylimidazolone derivatives as an antitumor agent
DE60114640D1 (en) Antithrombosemittel
PT2112154E (pt) Ésteres na posição 20 de camptotecinas
GB0212410D0 (en) Organic compounds
MXPA04005988A (es) 3,4-dihidro-1h-isoquinolin-2-il-derivados.
WO2004091627A3 (en) Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140813